Advancements in Prenatal Screening Trends: Market Research Report

December 2013 | 33 pages | ID: A9FD7D02667EN
Global Industry Analysts, Inc

Abstracts

The report illustrates the advancements in Prenatal Screening with a brief note on emerging developments in non-invasive prenatal screening, emerging developments in non-invasive prenatal testing, and emerging trends in the US non-invasive prenatal screening market. Prenatal diagnosis enables detection of chromosomal abnormalities and genetic mutations in human fetus, or embryo, at very early stage of pregnancy, including chromosome anomalies, neural tube defects, genetic abnormalities, Down's syndrome (trisomy 21 condition), and other conditions. In addition the report also highlights the role of the obstetricians, physicians and genetic counselors in helping the expectant mothers to arrive at an informed decision concerning prenatal screening.

Contents

1. ADVANCEMENTS IN PRENATAL SCREENING - A FOCUS REPORT

Prenatal Diagnosis - A Prelude

2. MARKET INFORMATION

Prenatal Screening Market Poised for Growth
Emerging Developments in Non-Invasive Prenatal Screening
Emerging Developments in Non-Invasive Prenatal Testing
Emerging Trends in the US Non-Invasive Prenatal Screening Market
Options Available for Prenatal Diagnostics
Emerging Developments in Prenatal Diagnostics Market
Emerging Trends in Molecular Diagnostics Market
Emerging Trends in Chinese Prenatal Testing Market

3. PRENATAL DIAGNOSIS - AN OVERVIEW

Screening Test vis-à-vis Diagnostic Test
Purpose of Prenatal Diagnosis
Conditions Specifically Tested for During Prenatal Diagnosis
Efficacy of Prenatal Screening
Negative Versus Positive Screens
Health Information Critical for Expectant Mothers
Neural Tube (NT) Abnormality and Chromosomal Anomaly
Other Fetal Disorders
Spinal Cord Abnormalities
Placental Abnormalities
Anatomy Abnormalities
A Typical Prenatal Diagnosis Cycle
First Trimester Combined Screening (FTS) - Technologies & Outcomes
Second Trimester Combined Test - Technologies & Outcomes
Routine Ultrasound - Technologies & Outcomes
Serum Integrated Prenatal Screen (SIPS) - Technology & Outcomes
Integrated Prenatal Screen (IPS) - Technology & Outcomes
Follow-up Action Based on Outcomes of Prenatal Screening

4. PRENATAL SCREENING – GUIDELINES & PROCEDURES

Prenatal Testing Decisions - Role of Physicians and Genetic Counselors
Testing Procedures for Prenatal Diagnosis
Maternal Serum Screening Cornerstone for Prenatal Diagnosis
Triple Tests and Quadruple Screen
Fetal Aneuploidy Screening
Procedures for Screening Fetal DNA
Amniocentesis
Chorionic Villus Sampling (CVS)
NT Ultrasound Scan
Morphology Ultrasound Scan
Genome-Wide Techniques
Efficacy of Blood Tests
Developments in Prenatal Diagnosis
Efficacy of Prenatal Diagnosis Techniques

5. EMERGING DEVELOPMENTS IN PRENATAL SCREENING TECHNOLOGIES

Emerging Screening Technologies
Prenatal Screening for Trisomy 21 Condition
Maternal Blood Sampling
Fetal DNA – Abnormality Testing
Genetic Profiling for Family Planning
Developments in Nasal Bone Analysis
Nasal Bone Sonography
Advances in Multiplex Fluorescent PCR
Development in Prenatal Screening for CF
Emerging Developments in Identification of Fetal Aneuploidy
Doppler Ultrasound of Ductus Venosus
Integrated First Trimester and Second Trimester Screening for Aneuploidy
Advancements in High-Speed MRI for Diagnosing Fetal Congenital Disorders
Advancements in 3D Ultrasound
Other Developments in Prenatal Screening
Technologies for Measuring DNA and Fetal Cells
Doppler Ultrasound for Noninvasive Screening of Fetal Anemia

6. NOTEWORTHY MARKET PARTICIPANTS

Ariosa Diagnostics, Inc. (USA)
Natera, Inc. (USA)
PerkinElmer, Inc. (USA)

7. CORPORATE INITIATIVES

BGI Pens an Agreement with GENNET
Illumina Takes Over BlueGnome

8. PRODUCT LAUNCHES/TECHNOLOGY INNOVATIONS

LABCO Introduces NIPD Test in Spain
LifeCodexx Unveils PraenaTest Service
University of Washington Launches Innovative NIPD Test
Ariosa Diagnostics Launches Launch Harmony
CUHK Launches safeT21
GSN Introduces Parental Support

9. APPENDIX